• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1994 Fiscal Year Final Research Report Summary

Three-Dimensional Structure of Human Tissue Factor

Research Project

Project/Area Number 05680539
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field Structural biochemistry
Research InstitutionNATIONAL CARDIOVASCULAR CENTER RESEARCH INSTITUTE

Principal Investigator

MIYATA Toshiyuki  Natl Cardiovascular Ctr Res Inst, Senior Staff, 脈管生理部, 室長 (90183970)

Co-Investigator(Kenkyū-buntansha) KOBAYASHI Yuji  Osaka Univ, Inst for Protein Res, Assistant Professor, 蛋白質研究所, 助教授 (20127228)
Project Period (FY) 1993 – 1994
KeywordsBlood coagulation / Tissue factor / NMR / Three-dimensional structure / Domain
Research Abstract

In the previous study involving a yeast expression system, a high molecular mass extracellular domain of human tissue factor (denoted as sTFalpha) with a high content of mannose residues was produced in abundance and 37 kDa sTFbeta was obtained in a low yield (Shigematsu et al.(1992) J.Biol.Chem.267,21329-21337). To obtain sTFbeta in a high yield, we constructed four kinds of mutant sTF with partial or total replacement of the N-potential glycosylation Asn residues with Ala, and expressed them in yeast. We found that the yield of the beta form of the Asn137-to-Ala mutant (designated as sTFbetaNNA) was three-fold higher (3mg/liter) than that of the wild type, suggesting that the replacement of one of the three potential N-glycosylation Asn residues with Ala could be a good way to minimize the addition of mannose repeats. High recovery of the 37 kDa sTFbeta now opened a way for the analysis of three-dimensional structure. Since it has been reported that calcium ions are required for the … More effective hydrolysis of peptidyl substrates by the factor VIIa-sTF complex, it is believed to be essential for the expression of full protease activity. Here, we report the enzymatic characterization of a factor VIIa-sTFbetaNNA complex cross-linked with a homobifunctional reagent, bis (sulfosuccinimidyl) suberate. The factor VIIa-sTFbetaNNA complex cross-linked in the presence of 5 mM calcium ions or 50 mM EDTA was purified. The cross-linked complex did not show factor X activation in the presence of phospholipids. However, it showed essentially the same activity toward peptidyl substrates as before cross-linking, even in the presence of EDTA.The kinetic constants of the cross-linked complexes in the presence of 5 mM calcium and 50 mM EDTA were similar, indicating that once factor VIIa was cross-linked with sTF,calcium ions were required no more for its activity. Therefore, calcium ions are not required for full catalytic activity of the factor VIIa-sTF complex toward synthetic substrates once the bi-molecular complex has formed. Less

  • Research Products

    (18 results)

All Other

All Publications (18 results)

  • [Publications] K.Kario ら: "Fluorogenic assay of activated factor VII:plasma factro VIIa levels in relation to arterial cardiovascular diseases in Japanese." Arterioscler,Thromb.14. 265-274 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] S.Kamei ら: "Amino acid sequence and inhibitory activity of Rhesus monkey tissue factor pathway inhibitor (TEPI):Comparison with human TFPI." J.Biochem.115. 708-714 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] T.Miyata ら: "Factor IX Bm Kiryu:A Val-313-to-Asp substitution in the catalytic domain results in loss of function due to a conformational change of the surface loop:Evidence obtained by chimeric modeling." Br.J.Haematol.88. 156-165 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] K.Hayashi ら: "Inhibition of serine proteases of the blood coagulation system by squash family protease inhibitors." J.Biochem.116. 1013-1018 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Y.Z.Zheng ら: "Six missense mutations associated with type I and type II protein C deficiency and implications obtained from molecular modeling." Blood Coagul.Fibrinolysis. 5. 687-696 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] T.Miyata ら: "Chemical cross-linking of activated coagulation factor VII with soluble tissue factor." J.Biochem.117(印刷中). (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 宮田敏行: "「ビタミンK(医学・生物学領域における新展開)」V.ビタミンK依存性蛋白質の構造とその機能、A.プロトロンビンファミリー、2)VII因子" メディカル ジャーナル社, 18 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 宮田敏行: "「血液病学、第2版」IV.止血と血栓(凝固と線溶)、D.血液凝固因子の産生・構造・機能、3.ビタミンK依存性凝固因子" 文光堂, 11 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] K.kario, T.Sakata, T.Matsuo, and T.Miyata: "Factor VII in non-insulin-dependent diabetic patients with microalbuminuria." Lancet. 342. 1552 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] K.Kario, T.Sakata, T.Matsuo, and T.Miyata: "Factor VII hyperactivity and ischaemic heart disease." Lancet. 343. 233 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] T.Miyata, Y.Z.Zheng, T.Sakata, N.Tsushima, and H.Kato: "Three missense mutations in the protein C heavy chain causing type I and type II protein C deficiency." Thromb.Haemost.71. 32-37 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] K.Kario, T.Miyata, T.Sakata, T.Matsuo, and H.Kato: "Fluorogenic assay of activated factor VII : plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese." Arterioscler.Thromb.14. 265-274 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] S.Kamei, Y.Kamikubo, T.Hamuro, H.Fujimoto, M.Ishifara, H.Yomemura, S.Miyamoto, A.Funatsu, K.Enjyoji, T.Abumiya, T.Miyata, and H.Kato: "Amino acid sequence and inhibitory activity of Rhesus monkey tissue factor pathway inhibitor (TFPI) : Comparison with human TFPI." J.Biochem.115. 708-714 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] T.Miyata, K.Kuze, T.Matsusue, H.Komooka, K.Kamiya, H.Umeyama, A.Matsui, H.Kato, and A.Yoshioka: "Factor IX Bm Kiryu : A Val-313-to-Asp substitution in the catalytic domain results in loss of function due to a conformational change of the surface loop : Evidence obtained by chimeric modeling." Br.J.Haematol.88. 156-165 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Y.Z.Zheng, T.Sakata, T.Matsusue, H.Umeyama, H.Kato, and T.Miyata: "Six missense mutations associated with type I and type II protein C deficiency and implications obtained from molecular modeling." Blood Coagul.Fibrinolysis. 5. 687-696 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] K.Hayashi, T.Takehisa, N.Hamato, R.Takano, S.Hara, T.Miyata, and H.Kato: "Inhibition of serine proteases of the blood coagulation system by squash family protease inhibitors." J.Biochem.116. 1013-1018 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] T.Sakata, K.Kario, T.Matsuo, Y.Katayama, T.Matsuyama, H.Kato, and T.Miyata: "Anticoagulation with warfarin and activated factor VII levels." Arterioscler.Thromb.February issue. (in press). (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] T.Miyata, A.Funatsu, and H.Kato: "Chemical cross-linking of activated coagulation factor VII with soluble tissue factor." J.Biochem., April issue. (in press). (1995)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1996-04-15  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi